Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Helleday

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Cancer Treatment and Research|November 17, 2023
Mitotic MTH1 Inhibitors in Treatment of CancerThomas Helleday
European Journal of Cancer (Oxford, England : 1990)|April 1, 2008
Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapyThomas Helleday
Molecular Oncology|August 9, 2011
The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandingsThomas Helleday
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
DNA repair as treatment targetThomas Helleday
Nature Structural & Molecular Biology|December 6, 2013
PrimPol breaks replication barriersThomas Helleday
Carcinogenesis|March 31, 2010
Homologous recombination in cancer development, treatment and development of drug resistanceThomas Helleday
Mutation Research|December 4, 2003
Pathways for mitotic homologous recombination in mammalian cellsThomas Helleday
Current Opinion in Oncology|October 8, 2013
Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practiceThomas Helleday
Current Biology : CB|February 5, 2010
Mutagenesis: mutating a gene while reading itThomas Helleday
The New England Journal of Medicine|October 15, 2015
Poisoning Cancer Cells with Oxidized NucleosidesThomas Helleday
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Cancer Treatment and Research|November 17, 2023
Mitotic MTH1 Inhibitors in Treatment of CancerThomas Helleday
European Journal of Cancer (Oxford, England : 1990)|April 1, 2008
Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapyThomas Helleday
Molecular Oncology|August 9, 2011
The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandingsThomas Helleday
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
DNA repair as treatment targetThomas Helleday
Nature Structural & Molecular Biology|December 6, 2013
PrimPol breaks replication barriersThomas Helleday
Carcinogenesis|March 31, 2010
Homologous recombination in cancer development, treatment and development of drug resistanceThomas Helleday
Mutation Research|December 4, 2003
Pathways for mitotic homologous recombination in mammalian cellsThomas Helleday
Current Opinion in Oncology|October 8, 2013
Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practiceThomas Helleday
Current Biology : CB|February 5, 2010
Mutagenesis: mutating a gene while reading itThomas Helleday
The New England Journal of Medicine|October 15, 2015
Poisoning Cancer Cells with Oxidized NucleosidesThomas Helleday
Pageof 28